These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function. Welink J, Boven E, Vermorken JB, Gall HE, van der Vijgh WJ. Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604 [Abstract] [Full Text] [Related]
15. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling. van den Bongard HJ, Mathôt RA, van Tellingen O, Schellens JH, Beijnen JH. Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107 [Abstract] [Full Text] [Related]
16. Plasma pharmacokinetics of high-dose oral melphalan in patients treated with trialkylator chemotherapy and autologous bone marrow reinfusion. Choi KE, Ratain MJ, Williams SF, Golick JA, Beschorner JC, Fullem LJ, Bitran JD. Cancer Res; 1989 Mar 01; 49(5):1318-21. PubMed ID: 2645050 [Abstract] [Full Text] [Related]
17. Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study. Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B. Clin Cancer Res; 1996 Jun 01; 2(6):947-52. PubMed ID: 9816255 [Abstract] [Full Text] [Related]